Overall, these results demonstrate that the IGF signaling pathway plays a critical role in the pathogenesis of gastric cancer and that IGF-1, IGFBP-4, and IGFBP-5, in particular, may serve as potential biomarkers for clinical applications. The gene discussed is IGFBP4; the disease is gastric cancer.